Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

Similar articles for PubMed (Select 24214904)

1.

Gadolinium-free T1 contrast agents for MRI: tunable pharmacokinetics of a new class of manganese porphyrins.

Cheng HL, Haedicke IE, Cheng W, Tchouala Nofiele J, Zhang XA.

J Magn Reson Imaging. 2014 Dec;40(6):1474-80. doi: 10.1002/jmri.24483. Epub 2013 Nov 8.

PMID:
24214904
2.

Gadolinium-free extracellular MR contrast agent for tumor imaging.

Nofiele JT, Haedicke IE, Zhu Yle K, Zhang XA, Cheng HL.

J Magn Reson Imaging. 2015 Feb;41(2):397-403. doi: 10.1002/jmri.24561. Epub 2014 Jan 8.

PMID:
24399613
3.

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.

Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.

Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.

PMID:
20351653
4.

Binding of a dimeric manganese porphyrin to serum albumin: towards a gadolinium-free blood-pool T1 MRI contrast agent.

Cheng W, Ganesh T, Martinez F, Lam J, Yoon H, Macgregor RB Jr, Scholl TJ, Cheng HL, Zhang XA.

J Biol Inorg Chem. 2014 Feb;19(2):229-35. doi: 10.1007/s00775-013-1073-6. Epub 2014 Jan 10.

PMID:
24407461
5.

Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.

Saito S, Obata A, Kashiwagi Y, Abe K, Murase K.

Invest Radiol. 2013 Jul;48(7):548-53. doi: 10.1097/RLI.0b013e3182856a06.

PMID:
23442774
6.

Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.

Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO.

Invest Radiol. 2008 Jul;43(7):504-11. doi: 10.1097/RLI.0b013e3181705cd1.

PMID:
18580333
7.

Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.

Doeblin P, Schilling R, Wagner M, Luhur R, Huppertz A, Hamm B, Taupitz M, Durmus T.

Eur J Radiol. 2014 Apr;83(4):660-4. doi: 10.1016/j.ejrad.2013.12.019. Epub 2013 Dec 27.

PMID:
24433640
8.

Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.

Fu Y, Raatschen HJ, Nitecki DE, Wendland MF, Novikov V, Fournier LS, Cyran C, Rogut V, Shames DM, Brasch RC.

Biomacromolecules. 2007 May;8(5):1519-29. Epub 2007 Apr 3.

PMID:
17402781
9.

Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.

Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J.

Invest Radiol. 2011 Sep;46(9):556-66. doi: 10.1097/RLI.0b013e31821a218a.

PMID:
21623212
10.
11.

Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.

Haimerl M, Verloh N, Zeman F, Fellner C, Müller-Wille R, Schreyer AG, Stroszczynski C, Wiggermann P.

PLoS One. 2013 Dec 31;8(12):e85658. doi: 10.1371/journal.pone.0085658. eCollection 2013.

12.
13.

Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.

Runge VM, Wells JW, Williams NM.

Invest Radiol. 1996 Dec;31(12):781-8.

PMID:
8970881
14.

T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T.

Lin K, Lloyd-Jones DM, Spottiswoode B, Bi X, Liu Y, Lu B, Xue H, Wang Y, Li D, Carr JC.

Invest Radiol. 2014 Apr;49(4):243-8. doi: 10.1097/RLI.0000000000000024.

PMID:
24473364
15.

Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.

Saito S, Moriyama Y, Kobayashi S, Ogihara R, Koto D, Kitamura A, Matsushita T, Nishiura M, Murase K.

J Magn Reson Imaging. 2012 Dec;36(6):1483-9. doi: 10.1002/jmri.23726. Epub 2012 Jun 18.

PMID:
22711439
16.
17.

A simple and inexpensive system for controlling body temperature in small animal experiments using MRI and the effect of body temperature on the hepatic kinetics of Gd-EOB-DTPA.

Murase K, Assanai P, Takata H, Saito S, Nishiura M.

Magn Reson Imaging. 2013 Dec;31(10):1744-51. doi: 10.1016/j.mri.2013.08.005. Epub 2013 Oct 2.

PMID:
24094686
18.

T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 Apr 28;14:26. doi: 10.1186/1532-429X-14-26.

19.

Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.

Jia J, Puls D, Oswald S, Jedlitschky G, Kühn JP, Weitschies W, Hosten N, Siegmund W, Keiser M.

Invest Radiol. 2014 Feb;49(2):78-86. doi: 10.1097/RLI.0b013e3182a70043.

PMID:
24056116
20.

Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.

Kaneshiro TL, Ke T, Jeong EK, Parker DL, Lu ZR.

Pharm Res. 2006 Jun;23(6):1285-94. Epub 2006 Jun 1.

PMID:
16729223
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk